107 related articles for article (PubMed ID: 9549342)
1. [Improvement of drug bioavailability using protease inhibitors].
Zhaopeng H; Kimura G; Yoshikawa Y; Takada K
Nihon Rinsho; 1998 Mar; 56(3):595-600. PubMed ID: 9549342
[TBL] [Abstract][Full Text] [Related]
2. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
Bernkop-Schnürch A
J Control Release; 1998 Mar; 52(1-2):1-16. PubMed ID: 9685931
[TBL] [Abstract][Full Text] [Related]
3. Polycarbophil-cysteine conjugates as platforms for oral polypeptide delivery systems.
Bernkop-Schnürch A; Thaler SC
J Pharm Sci; 2000 Jul; 89(7):901-9. PubMed ID: 10861591
[TBL] [Abstract][Full Text] [Related]
4. [Methodologies for regulation of intestinal absorption of biologically active peptides].
Fujita T; Muranishi S
Nihon Rinsho; 1998 Mar; 56(3):589-94. PubMed ID: 9549341
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional matrices for oral peptide delivery.
Bernkop-Schnürch A; Walker G
Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
[TBL] [Abstract][Full Text] [Related]
6. Theoretical approaches and practical investigations in carbopol buccal patches for drug delivery.
Guo JH; Cooklock KM
Drug Dev Ind Pharm; 1998 Feb; 24(2):175-8. PubMed ID: 15605448
[TBL] [Abstract][Full Text] [Related]
7. [Improvement of transmucosal absorption of biologically active peptide drugs].
Yamamoto A
Yakugaku Zasshi; 2001 Dec; 121(12):929-48. PubMed ID: 11766407
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin.
Luessen HL; Verhoef JC; Borchard G; Lehr CM; de Boer AG; Junginger HE
Pharm Res; 1995 Sep; 12(9):1293-8. PubMed ID: 8570524
[TBL] [Abstract][Full Text] [Related]
9. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
Lehr CM
Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):119-60. PubMed ID: 7600586
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.
Werle M; Takeuchi H
Int J Pharm; 2009 Mar; 370(1-2):26-32. PubMed ID: 19073243
[TBL] [Abstract][Full Text] [Related]
11. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.
Yamamoto A; Ukai H; Morishita M; Katsumi H
Pharmacol Ther; 2020 Jul; 211():107537. PubMed ID: 32201316
[TBL] [Abstract][Full Text] [Related]
12. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
Yamamoto A
Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive polymers for buccal drug delivery.
Laffleur F
Drug Dev Ind Pharm; 2014 May; 40(5):591-8. PubMed ID: 24576266
[TBL] [Abstract][Full Text] [Related]
14. Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.
Vyas SP; Venugopalan P; Sood A; Mysore N
Pharmazie; 1997 May; 52(5):339-45. PubMed ID: 9183784
[TBL] [Abstract][Full Text] [Related]
15. Effect of protease inhibitors on pulmonary bioavailability of therapeutic proteins and peptides in the rat.
Amancha KP; Hussain A
Eur J Pharm Sci; 2015 Feb; 68():1-10. PubMed ID: 25460544
[TBL] [Abstract][Full Text] [Related]
16. Oral colon-specific drug delivery of protein and peptide drugs.
Sinha V; Singh A; Kumar RV; Singh S; Kumria R; Bhinge J
Crit Rev Ther Drug Carrier Syst; 2007; 24(1):63-92. PubMed ID: 17430100
[TBL] [Abstract][Full Text] [Related]
17. The metabolic barrier of the lower intestinal tract of salmon to the oral delivery of protein and peptide drugs.
Ledger R; Tucker IG; Walker GF
J Control Release; 2002 Dec; 85(1-3):91-103. PubMed ID: 12480315
[TBL] [Abstract][Full Text] [Related]
18. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.
Aguirre TA; Teijeiro-Osorio D; Rosa M; Coulter IS; Alonso MJ; Brayden DJ
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):223-241. PubMed ID: 26921819
[TBL] [Abstract][Full Text] [Related]
19. [Improvement of Intestinal and Transmucosal Absorption of Peptide and Protein Drugs].
Yamamoto A
Yakugaku Zasshi; 2024; 144(7):697-714. PubMed ID: 38945845
[TBL] [Abstract][Full Text] [Related]
20. Effects of polyacrylic polymers on the lumenal proteolysis of peptide drugs in the colon.
Bai JP; Chang LL; Guo JH
J Pharm Sci; 1995 Nov; 84(11):1291-4. PubMed ID: 8587045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
